Sun Pharma Signs Non-Exclusive Patent Licensing Deal with Takeda for Vonoprazan
Sun Pharma has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company Ltd. to commercialise Vonoprazan tablets 10 mg, 20 mg in India under the brand name Voltapraz.
Patent Licensing | 24/06/2024 | By Aishwarya | 305
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy